Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 185, pseudogene (RN7SL185P) is classified as a pseudogene of the 7SL RNA family, similar in sequence to the functional 7SL RNA gene but lacking known function or protein-coding potential[7]. 7SL RNA is a non-coding RNA component of the signal recognition particle (SRP), a complex critical for cotranslational targeting of proteins to the endoplasmic reticulum[1][4]. Pseudogenes like RN7SL185P are generally considered non-functional genomic elements, though some pseudogenes transcribe non-coding RNAs that may, in certain contexts, act as microRNA sponges or modulate gene regulation indirectly[2]. There is no evidence that RN7SL185P acts as a receptor, enzyme, transporter, or that it serves as a therapeutic target. There is no known disease association, no drugs known to interact with this pseudogene, and no known utility as a biomarker. The listing of RN7SL185P as a drug target or molecular receptor is incorrect: it is a non-coding RNA pseudogene, not a druggable or functional gene product[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 185, pseudogene (RN7SL185P).